Back

Prophylactic ablation of preexcitation: when and for whom?

29 August 2021 (09:30 - 09:41)
Organised by:
Congress Presentation Part of: Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Josep Brugada Terradellas

Hospital Clinic of Barcelona, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Treatment of asymptomatic PVCs: when should it be attempted?
Professor T. Reichlin (Bern, CH)
Slides Video
Presentation thumbnail
What is the optimal treatment of asymptomatic patients with primary electrical syndromes?
Professor K. Haugaa (Oslo, NO)
Slides Video
Presentation thumbnail
Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? – discussion.
Video
Presentation thumbnail
Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? - Chat Moderator.

Access the full session

Session thumbnail
Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 09:30 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
thumbnail
Congress Session
The storm will pass…

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources